Advanced Medical Solutions Grp PLC
10 July 2003
Advanced Medical Solutions Group plc ('the Company' or 'AMS')
Holding in Company
The Company received notification on 8 July 2003 that, following a purchase of
200,000 ordinary shares in AMS on 8 July 2003, AMVESCAP PLC ('AMVESCAP') and its
subsidiary companies on behalf of discretionary clients has an interest in
14,324,938 ordinary shares, representing approximately 10.08 per cent. of the
Company's issued share capital. These ordinary shares are registered as follows:
Chase Nominees Limited 9,418,564
Vidacos Nominees Ltd 4,906,374
None of these shares is beneficially owned by AMVESCAP. This notification has
been made by AMVESCAP as Investment manager and investment advisor by virtue of
Section 203 of the Companies Act 1985.
Within the holding disclosed above, INVESCO English and International Trust has
an interest in 7,812,159 ordinary shares, representing approximately 5.50 per
cent. of the Company's issued share capital, registered in the name of Chase
Nominees Limited.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.